BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 991 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $111,107 | -20.3% | 2,944 | -3.8% | 0.02% | -16.7% |
| Q2 2023 | $139,369 | +14.4% | 3,059 | +1.9% | 0.02% | +5.9% |
| Q1 2023 | $121,802 | -4.3% | 3,003 | +20.3% | 0.02% | -15.0% |
| Q4 2022 | $127,221 | -9.1% | 2,496 | -4.3% | 0.02% | -16.7% |
| Q3 2022 | $140,000 | -16.7% | 2,607 | -0.6% | 0.02% | -17.2% |
| Q2 2022 | $168,000 | -14.7% | 2,623 | +3.3% | 0.03% | -3.3% |
| Q1 2022 | $197,000 | -12.1% | 2,540 | -2.8% | 0.03% | -9.1% |
| Q4 2021 | $224,000 | +7.7% | 2,614 | +1.2% | 0.03% | -2.9% |
| Q3 2021 | $208,000 | +3.0% | 2,582 | +2.8% | 0.03% | 0.0% |
| Q2 2021 | $202,000 | -1.9% | 2,511 | +2.7% | 0.03% | -10.5% |
| Q1 2021 | $206,000 | +5.6% | 2,445 | +0.7% | 0.04% | +2.7% |
| Q4 2020 | $195,000 | 0.0% | 2,429 | 0.0% | 0.04% | -9.8% |
| Q3 2020 | $195,000 | -3.5% | 2,429 | +3.4% | 0.04% | -14.6% |
| Q2 2020 | $202,000 | +5.8% | 2,350 | 0.0% | 0.05% | -4.0% |
| Q1 2020 | $191,000 | -3.0% | 2,350 | 0.0% | 0.05% | +16.3% |
| Q4 2019 | $197,000 | -4.4% | 2,350 | 0.0% | 0.04% | -8.5% |
| Q3 2019 | $206,000 | +7.3% | 2,350 | 0.0% | 0.05% | +6.8% |
| Q2 2019 | $192,000 | +0.5% | 2,350 | 0.0% | 0.04% | -4.3% |
| Q1 2019 | $191,000 | +23.2% | 2,350 | 0.0% | 0.05% | +7.0% |
| Q4 2018 | $155,000 | -14.4% | 2,350 | 0.0% | 0.04% | -4.4% |
| Q3 2018 | $181,000 | +1.7% | 2,350 | -2.2% | 0.04% | -2.2% |
| Q2 2018 | $178,000 | +14.1% | 2,404 | 0.0% | 0.05% | +12.2% |
| Q1 2018 | $156,000 | 0.0% | 2,404 | -0.2% | 0.04% | -2.4% |
| Q4 2017 | $156,000 | +2.0% | 2,410 | -1.3% | 0.04% | -2.3% |
| Q3 2017 | $153,000 | +3.4% | 2,441 | 0.0% | 0.04% | -2.3% |
| Q2 2017 | $148,000 | +16.5% | 2,441 | 0.0% | 0.04% | +10.0% |
| Q1 2017 | $127,000 | +17.6% | 2,441 | 0.0% | 0.04% | +2.6% |
| Q4 2016 | $108,000 | -6.9% | 2,441 | +0.5% | 0.04% | -7.1% |
| Q3 2016 | $116,000 | +7.4% | 2,428 | +1.2% | 0.04% | +7.7% |
| Q2 2016 | $108,000 | +11.3% | 2,399 | +2.1% | 0.04% | 0.0% |
| Q1 2016 | $97,000 | +7.8% | 2,350 | 0.0% | 0.04% | +11.4% |
| Q4 2015 | $90,000 | +16.9% | 2,350 | 0.0% | 0.04% | 0.0% |
| Q3 2015 | $77,000 | -53.0% | 2,350 | 0.0% | 0.04% | -47.8% |
| Q2 2015 | $164,000 | +1.9% | 2,350 | 0.0% | 0.07% | 0.0% |
| Q1 2015 | $161,000 | -6.4% | 2,350 | 0.0% | 0.07% | -14.1% |
| Q4 2014 | $172,000 | – | 2,350 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |